Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients
{{output}}
Introduction: Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy for the treatment of refractory hematopoietic malignancies. Adverse events are common, and neurotoxicity is one of the most important. However, the physiopathology is unk... ...
